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Abstract
Background: Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm usually found in the pleura, soft tissues
and visceral organs. We describe one case arising in the mesentery, which is an exceptional localization.
Case presentation: A 71-year-old man was referred to our establishment for a painless hypogastric mass. Further
investigation revealed a vascular tumor, which was resected en bloc. Pathological findings confirmed solitary fibrous
tumor of the mesentery.
Conclusion: This is the second case of solitary fibrous tumor of the small intestine mesentery ever reported. It was
managed by en bloc resection and close follow up considering the high risk of recurrence. Investigation should be
made regarding the use of adjuvant systemic therapy to improve long-term survival for these patients.
Background
Solitary fibrous tumor is a rare mesenchymal neoplasm
first described in the pleura, in 1870, by Wagner [1].
Postulated cells of origin comprise fibroblasts, myofibro-
blasts endothelial cells, as well as pericytes [2]. It usually
arises in the pleura, pericardium, soft tissues and visc-
eral organs [2]. We report a case with an unusual locali-
zation in the mesentery. To our knowledge, this case
would be the second reported case arising in the small
intestine mesentery [3-7].
Case presentation
A 71-year-old man was referred to the medical oncology
department for the incidental finding of a palpable
hypogastric mass. The patient did not complain of
abdominal pain or any other gastrointestinal symptoms.
He was in good general condition, with no relevant past
medical history, except for a right total hip replacement
that the patient underwent 10 years previously. A percu-
taneous biopsy was initially done to rule out a possible
lymphoma. The pathology results were however consis-
tent with a hemangiopericytoma or a solitary fibrous
tumor. The patient was then referred to our surgical
oncology department for resection. Abdominal CT scan
with contrast revealed a fibrous tumor at the root of the
mesentery, surrounding the superior mesenteric vein.
There was neither thrombosis, nor hepatic or lymphatic
involvement and the tumor seemed resectable. On
March 12th 2010, the patient underwent surgery with
complete resection of the mesenteric tumor as well as
22 cm of small intestine (Figure 1). The patient had an
uneventful recovery and was discharged 6 days after
surgery.
Gross pathologic examination revealed a 15,5 × 14 × 9
cm multinodular lesion. It was solid, pink-to-gray
shaded and well vascularised without any macroscopic
necrosis. It had no attachment to the intestinal wall, and
presented an infiltrative pattern at the root of the
mesentery. The small intestine portion was normal and
the margins were clear. The specimen was submitted for
histopathologic study, which was in favor of a malignant
solitary fibrous tumor. Indeed, the tumor was more than
15 cm, and presented 6 mitoses per 10 high-power fields
(HPF). Immunohistochemical studies revealed cells
strongly positive to CD34 antibody (common in this
type of neoplasm [5,8]) (Figure 2A), with focal CD99
membranous expression.
At twelve months of follow-up, there was no recur-
rence of the tumor.
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Solitary fibrous tumor arising in the mesentery is an
extremely unusual location for this type of tumor.
These tumors arise mostly in serosal surfaces of the
pleura and pericardium [9]. Many extrapleural localiza-
tions have been previously reported including: retroperi-
toneum, deep soft tissues of proximal extremities (thigh,
axilla), abdominal cavity, kidneys, trunk, and head and
neck (including the orbit and meninges) [3] and only
one previous case in the same localization [9]; mesen-
tery of the small intestine.
Solitary fibrous tumors arise in patients with a median
age of 40 to 60, and show no sex or race predominance.
Our patient presented with a painless abdominal mass,
which seems to be the case for most intra-abdominal
SFT tumors [10].
From a strictly pathologic standpoint, great confusion
exists in the literature regarding the origin, evolution
and classification of solitary fibrous tumors. Indeed, soli-
tary fibrous tumors and hemangiopericytomas (HPC)
share many pathological findings. Overlapping nonspeci-
fic histologic features such as branching staghorn vessels,
immunohistochemical CD34/CD99 reactivity, as well as
ultrastructural pericytic, fibroblastic and/or myofibro-
blastic differentiation, renders difficult the differentiation
of these tumors. The tendency is now one of considering
HPC and SFT as being part of the same entity, with a
broad morphological spectrum of differentiation.
Many tumors may contain areas mimicking SFT/HPC,
therefore the differential diagnosis must be thoroughly
reviewed and investigated. It comprises GIST, synovial
sarcoma, leiomyosarcoma, undifferentiated liposarcoma,
myofibroblastoma, metastasis from a spindle-cell carci-
noma, malignant peripheral nerve sheath tumor (MPNST),
as well as low grade fibromyxoid sarcoma [2,11].
Given that the specimen revealed cells strongly posi-
tive to CD34 antibody and focal CD99 membranous
expression, the diagnosis was in favour of a solitary
fibrous tumor [2,11]. Moreover, immunohistochemical
study with CD117 marker was performed and did not
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Figure 1 Solitary fibrous tumor of the mesentery.
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Figure 2 2A. High diffuse positivity to anti-CD34. 2B. Vessels revealing a herringbone pattern.
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Bcl-2 antigen study (positive in 30% of SFTs [2]) was
not done, since it was not required for the differential
diagnosis. Extensive sampling did not reveal any lipo-
blastic differentiation, thus excluding dedifferentiated
liposarcoma. Immunhistochemistry did not show any
S-100 or SMA positivity eliminating the possibility of
MPNST and leiomyosarcoma. Monophasic synovial
sarcoma is at times difficult to distinguish from SFT.
Diffuse expression of CD34 and absence of EMA
favours SFT. Low grade myofibroblastic sarcomas
usually show focal myxoid stroma and are normally
CD34 negative.
The histopathologic study is important to establish
prognosis of the tumor, since there is no grading scale
per se for SFT [2]. Malignant nature is generally con-
veyed by a large tumor size (> 50 mm) [5,10,12] high
cellularity, nuclear pleomorphism [11], mitotic activity
(> 4 per 10 HPF), anaplasia, necrosis and hemorrhage
[9,10]. In our case, the presence of nuclear polymorph-
ism with hypercellularity, increased mitotic activity,
tumor size, as well as a focally infiltrative interface are
consistant with a malignant nature for this tumor.
Treatment of intra-abdominal SFT/HPC usually
implies complete en bloc surgical resection with negative
margins [9,10,13,14]. Radiotherapy is an adjunctive ther-
apy that has been used in several patients. In our case,
since the tumor was located centrally in the abdomen,
surgical treatment without radiotherapy was favoured, in
order to avoid the high risk of toxicity to the small
bowel. The literature also reports the use of doxorubicin
to achieve a partial response in patients with non resect-
able or advanced SFT’s [10]. Use of interferon-alpha has
also been reported, with resulting stabilization of the
tumor [9]. However, no such reports exist for adjuvant
systemic treatment.
Due to the rarity of solitary fibrous tumors in this par-
ticular location as well as the confusion regarding the
pathological diagnosis, guidelines for treatment remain
currently unclear. The outcome does not seem to be
strongly related to the morphology of the tumor: even
though tumors showing malignant features may behave
aggressively, some tumors considered benign may recur
and metastasize [2]. The prognosis of SFT is not well
known, but the rate of recurrence and metastases is
quite high (up to 50%) [10], occuring even years later
(ad 24 years, as reported by Rew and Allen in 1986
[15]). These tumors mainly spread haematogenously,
and the lungs, liver and bone are the most common
sites for metastases.
Solitary fibrous tumors are rare. Treatment consists in
complete surgical resection. Considering that recurrence
and metastases are common following surgery, long
term follow up is necessary [13,5]. There is currently an
unmet medical need regarding adjuvant treatment to try
to improve long-term survival.
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